Product Program year 2022 Source: CMS Open Payments

FACSVia

Device Cell Analysis

PDI 00382906623867

Open in the dashboard

General payments

$567,897

262 payments

Research payments

$0

0 payments

Through program year 2022, $567,897 in general payments and $0 in research payments were reported against FACSVia (Cell Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $567,897 262

Breakdown

Who paid General payments · program year 2022
  1. Becton, Dickinson and Company $567,897 262 payments
Top recipients General payments · program year 2022
  1. Childrens Hospital Corporation Teaching hospital · MA $149,213 26% · 59 payments
  2. University Of Washington Med Ctr Teaching hospital · WA $136,612 24% · 26 payments
  3. Dana-Farber Cancer Institute Teaching hospital · MA $81,986 14% · 34 payments
  4. Brigham And Womens Hospital Teaching hospital · MA $76,074 13% · 48 payments
  5. Hospital Of The Univ Of Penna Teaching hospital · PA $43,721 8% · 22 payments

The top 5 of 16 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Hematology & Oncology Internal Medicine $27,555 87% · 1 practitioner
  2. Clinical & Laboratory Immunology Allergy & Immunology $3,723 12% · 1 practitioner
  3. Hematology Pathology $276 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Massachusetts $331,632 58% · 6 recipients
  2. Washington $164,167 29% · 2 recipients
  3. Pennsylvania $43,721 8% · 1 recipient
  4. Texas $15,426 3% · 2 recipients
  5. Oregon $7,798 1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

262 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record